Skip to main content

Exclusives

News
01/09/2025
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424...
01/09/2025
Wound Care
News
01/09/2025
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren,...
01/09/2025
Wound Care
News
01/09/2025
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that...
01/09/2025
Wound Care
News
01/09/2025
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar...
01/09/2025
Wound Care
News
01/09/2025
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has...
01/09/2025
Wound Care
News
01/09/2025
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient...
01/09/2025
Wound Care
News
01/09/2025
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has...
01/09/2025
Wound Care
News
01/08/2025
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA...
01/08/2025
Wound Care
Market Responds to Final MAC LCDs
Blog
01/08/2025
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally...
01/08/2025
Wound Care
News
12/30/2024
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the...
12/30/2024
Wound Care